OKT3 treatment of steroid- and/or anti-thymocyte globulin-resistant renal allograft rejection occurring on triple baseline immunosuppression including cyclosporine a
Widmer, U.; Frei, D.; Keusch, G.; Burger, H.R.; Largiader, F.; Binswanger, U.
Transplantation Proceedings 20(5 Suppl 6: 90-95
1988
ISSN/ISBN: 0041-1345 PMID: 3140454 Document Number: 321366
Document emailed within 1 workday
Related Documents
Tellis, V.A.; Matas, A.J.; Quinn, T.A.; Glicklich, D.; Weiss, R.J.; Soberman, R.J.; Veith, F.J. 1987: Antilymphoblast globulin treatment of steroid-resistant rejection in cyclosporine-immunosuppressed renal transplant recipients Transplantation Proceedings 19(1 Part 3): 1892Wang, X.H.; Xie, T. 1993: Anti-CD3 and -CD4 monoclonal antibody in the treatment of steroid-resistant renal allograft rejection Chinese Medical Journal 106(11): 821-824
Haberal, M.; Sert, S.; Gülay, H.; Arslan, G.; Bilgin, N. 1990: The treatment of steroid-resistant renal allograft rejection with OKT3 and plasmapheresis Transplantation Proceedings 22(4): 1761-1763
Palmer, J.; Slook, P. 1992: Successful use of Orthoclone OKT 3 for steroid-resistant acute rejection in pediatric renal allograft recipients Anna Journal 19(4): 375-377
Paul, L.C.; Chea, R.; Davidoff, A.; Benediktsson, H. 1994: Efficacy of long-term cyclosporine treatment to prevent chronic renal allograft rejection in the rat Transplantation Proceedings 26(5): 2567-2568
Valderrábano, F.; Anaya, F.; Robles, N.R.; Jofré, R. 1988: Sequential therapy with anti-thymocyte globulin and cyclosporine a in oligoanuric high-risk cadaveric kidney graft recipients Transplantation Proceedings 20(5 Suppl 6: 75-78
Rigotti, P.; Flechner, S.M.; Van Buren, C.T.; Payne, W.T.; Kahan, B.D. 1986: Increased incidence of renal allograft thrombosis under cyclosporine immunosuppression International Surgery 71(1): 38-41
Kawaguchi, H.; Komatsu, Y.; Hattori, M.; Nagata, M.; Ito, K.; Takahashi, K.; Teraoka, S.; Toma, H.; Ota, K. 1989: Somatic growth and renal function in pediatric renal transplantation with alternate-day steroid immunosuppression using cyclosporine (CsA) in Japan Transplantation Proceedings 21(1 Part 2): 1698-1700
Merion, R.M.; White, D.J.; Calne, R.Y. 1983: Early renal allograft rejection episodes are less aggressive with cyclosporin-A immunosuppression Transplantation Proceedings 15(4): 2172-2177
Gruber, S.A.; Skjei, K.L.; Sothern, R.B.; Robison, L.; Tzardis, P.; Moss, A.; Gillingham, K.; Canafax, D.M.; Matas, A.J.; Dunn, D.L. 1991: Cancer development in renal allograft recipients treated with conventional and cyclosporine immunosuppression Transplantation Proceedings 23(1 Pt 2): 1104-1105
Noël, C.; Hazzan, M.; Coppin, M.C.; Pruvot, F.R.; Bridoux, F.; Lelièvre, G. 1995: Renal transplant artery thrombosis following treatment of allograft rejection with monoclonal anti-CD3 antibodies (OKT3) Transplantation Proceedings 27(4): 2438-2439
Ratcliffe, P.J.; Firth, J.D.; Higgins, R.M.; Smith, B.; Gray, D.W.; Morris, P.J. 1993: Randomized controlled trial of complete steroid withdrawal in renal transplant patients receiving triple immunosuppression Transplantation Proceedings 25(1 Part 1): 590
Lácha, J.; Lehmann, M.; Chadimová, M.; Brock, J.; Havlícková, J. 1994: Effect of anti-CD4 monoclonal antibody and cyclosporine a or a combination of both on chronic rejection in the rat aortic allograft model Transplantation Proceedings 26(6): 3242-3243
Isoniemi, H.; Kyllönen, L.; Eklund, B.; Höckerstedt, K.; Salmela, K.; von Willebrand, E.; Ahonen, J. 1995: Acute rejection under triple immunosuppressive therapy does not increase the risk of late first cadaveric renal allograft loss Transplantation Proceedings 27(1): 875-877
McLigeyo, S.O.; Notghi, A.; Anderton, J.L.; Dick, J. 1990: Acute renal allograft rejection: the role of monoclonal antibodies in treatment: experience with orthoclonal anti-T3 cell antibody East African Medical Journal 67(9): 667-673
Nakagawa, Y.; Ikeda, M.; Tasaki, M.; Saito, K.; Takahashi, K. 2013: The new immunosuppressive drugs for renal transplantation: inhibitors of the mammalian target of rapamycin (mTOR) and anti-thymocyte globulin (Thymoglobulin) Nihon Jinzo Gakkai Shi 55(2): 112-118
Troncoso, P.; Stepkowski, S.M.; Wang, M.E.; Qu, X.; Chueh, S.C.; Clark, J.; Kahan, B.D. 1999: Prophylaxis of acute renal allograft rejection using FTY720 in combination with subtherapeutic doses of cyclosporine Transplantation 67(1): 145-151
Williamson, E.P.; Millar, R.J.; Criddle, R.A.; Sells, R.A. 1987: The differentiation of acute renal allograft rejection and cyclosporine nephrotoxicity by simple urine cytology Transplantation Proceedings 19(1 Part 2): 1785-1786
Hengster, P.; Pescovitz, M.D.; Hyatt, D.; Margreiter, R. 1999: Cytomegalovirus infections after treatment with daclizumab, an anti IL-2 receptor antibody, for prevention of renal allograft rejection. Roche Study Group Transplantation 68(2): 310-313
Abouna, G.M.; Kumar, M.S.; Stephan, R.; Prior, J.E.; Lyons, P.; Bulova, S.I.; al-Abdullah, I.H. 1993: Induction therapy with antithymocyte globulin reduces the incidence of allograft rejection and improves graft survival in cadaver renal transplantation Transplantation Proceedings 25(3): 2241-2242